Mediwound Ltd (MDWD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $185.63M
Last updated: Nov 17, 2026 at 4:10 PM ET
Mediwound Ltd (MDWD) Statistics
Mediwound (MDWD) has a market cap of $185.63M and an enterprise value of $166.09M. It kept -234.98% of revenue as net income over the last 12 months. Its share count is up 18.15% from a year earlier.
Total Valuation
Enterprise value is 10.53% below the market cap, as cash exceeds debt.
| Market Cap | $185.63M |
|---|---|
| Enterprise Value | $166.09M |
| Latest price (Nov 17, 2026) | $13.68 |
Key Dates
The next earnings report is expected on Mar 3, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 3, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 17.8x and 5.6x. Its year-end P/S ranged from 2.6x to 64.2x from 2016 to 2025.
| P/S Ratio | 17.8x |
|---|---|
| Forward P/S | 9.0x |
| P/B Ratio | 5.6x |
Price Statistics
The stock is down 25.04% over 52 weeks and trades 3.56% above its 50-day average.
| Beta (1Y) | 0.77 |
|---|---|
| 52-Week Change | -25.04% |
| 1-Month Change | +7.72% |
| 3-Month Change | +0.66% |
| 6-Month Change | -18.01% |
| 5-Year Change | -46.01% |
| 10-Year Change | -70.30% |
| Total Return (1Y) | -25.04% |
| Total Return (3Y CAGR) | +17.98% |
| Total Return (5Y CAGR) | -7.34% |
| Return vs SPY (1Y) | -36.72% |
| Max Drawdown (1Y) | -38.82% |
| Max Drawdown (3Y) | -46.72% |
| Sharpe Ratio (1Y) | -0.68 |
| Correlation with SPY (1Y) | 0.25 |
| 50-Day Average | $13.21 |
| 200-Day Average | $15.00 |
| 52-Week Range | $11.80 to $19.70 |
| RSI (14 Days) | 53.8 |
| Average Volume (20 Days) | 164.72K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.23x current liabilities, and total debt is 0.26x shareholder equity.
| Current Ratio | 2.23x |
|---|---|
| Quick Ratio | 1.99x |
| Debt / Equity | 0.26x |
Returns and Efficiency
Return on invested capital is -66.94% over the last 12 months, against a 5-year average of 100.62%.
| Return on Equity (ROE) | -73.97% |
|---|---|
| Return on Assets (ROA) | -35.90% |
| Return on Invested Capital (ROIC) | -66.94% |
| ROA (5Y Average) | -37.35% |
| ROIC (5Y Average) | 100.62% |
| Asset Turnover | 0.13x |
| Inventory Turnover | 2.03x |
| Receivables Turnover | 2.60x |
| Cash Conversion Cycle | -27 days |
Scores
MDWD has an Altman Z-Score of 2.33, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.33 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $10.01M over the last 12 months is down 52.19% from the 12 months before.
| Revenue | $10.01M |
|---|---|
| Revenue Growth (YoY) | -52.19% |
| Gross Profit | $1.95M |
| Operating Income | -$33.80M |
| Pretax Income | -$23.34M |
| Net Income | -$23.51M |
| Reported EPS (TTM) | -$2.21 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 48.53% of the $65.50M in total assets.
| Cash and Equivalents | $27.85M |
|---|---|
| Total Debt | $8.30M |
| Net Cash | $19.55M |
| Net Cash Per Share | $1.50 |
| Working Capital | $19.77M |
| Shareholder Equity | $31.79M |
| Book Value Per Share | $2.44 |
| Total Assets | $65.50M |
| Total Liabilities | $33.70M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $6.14M of capital spending, operating cash flow left -$32.56M of free cash flow.
| Operating Cash Flow | -$26.41M |
|---|---|
| Capital Expenditures | $6.14M |
| Free Cash Flow | -$32.56M |
| FCF Per Share | -$2.26 |
| Depreciation and Amortization | $1.86M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -337.76%, against a 5-year average of -80.80%.
| Gross Margin | 19.54% |
|---|---|
| Operating Margin | -337.76% |
| Pretax Margin | -233.25% |
| Net Margin | -234.98% |
| FCF Margin | -325.33% |
| Gross Margin (5Y Average) | 27.59% |
| Operating Margin (5Y Average) | -80.80% |
| Net Margin (5Y Average) | -91.44% |
Growth
Revenue fell 13.82% a year over 3 years.
| Revenue Growth (3Y CAGR) | -13.82% |
|---|---|
| Revenue Growth (5Y CAGR) | -4.87% |
| Book Value Per Share Growth (2Y CAGR) | -0.36% |
| Tangible Book Per Share Growth (2Y CAGR) | -0.14% |
Dividends and Yields
MDWD does not pay a dividend. Its free cash flow yield is -18.27%.
| FCF Yield | -18.27% |
|---|---|
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 1-for-7 reverse split on Dec 20, 2022.
| Last Split Date | Dec 20, 2022 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:7 |
Peer Position
Against 7 similar companies, MDWD has the 4th highest P/S.
P/S RatioPeer median 2.8x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +2.54%
| P/S Ratio | 17.8x vs 2.8x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -52.19% vs +2.54% median |
Analyst Forecast
Consensus estimates put revenue growth at 31.11% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +31.11% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About MDWD
What is MDWD's market cap?
Mediwound has a market cap of $185.63M. Its enterprise value, which adds debt and subtracts cash, is $166.09M.
How many shares of MDWD are outstanding?
Mediwound has 13.02M shares outstanding. The count is up 18.15% from a year earlier.
Does MDWD pay a dividend?
No. Mediwound does not pay a dividend.
How much debt does MDWD have?
Mediwound has $8.30M of total debt and $27.85M of cash and equivalents, a net cash position of $19.55M.
MDWD pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts